Constrained peptides with target-adapted cross-links as inhibitors of a pathogenic protein-protein interaction
about
Spacer-free BODIPY fluorogens in antimicrobial peptides for direct imaging of fungal infection in human tissueDouble Strain-Promoted Macrocyclization for the Rapid Selection of Cell-Active Stapled PeptidesConstraining an Irregular Peptide Secondary Structure through Ring-Closing Alkyne MetathesisCharacterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Designβ-Turn mimetic-based stabilizers of protein-protein interactions for the study of the non-canonical roles of leucyl-tRNA synthetase.Small molecules, peptides and natural products: getting a grip on 14-3-3 protein-protein modulation.EMBO conference series: Chemical Biology 2014Targeting protein-protein interfaces using macrocyclic peptides.Protein-protein interactions as drug targets.Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction.Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase.New Modalities for Challenging Targets in Drug Discovery.Modulating protein-protein interactions: the potential of peptides.Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.A Blind Test of Computational Technique for Predicting the Likelihood of Peptide Sequences to Cyclize.Targeting recognition surfaces on natural proteins with peptidic foldamersPeptides and peptidomimetics as regulators of protein-protein interactions.Orthogonal ring-closing alkyne and olefin metathesis for the synthesis of small GTPase-targeting bicyclic peptides.Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening.A Binary Bivalent Supramolecular Assembly Platform Based on Cucurbit[8]uril and Dimeric Adapter Protein 14-3-3.A Synthetic Loop Replacement Peptide That Blocks Canonical NF-κB Signaling.Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.Thermodynamic origin of α-helix stabilization by side-chain cross-links in a small protein.Increased Conformational Flexibility of a Macrocycle-Receptor Complex Contributes to Reduced Dissociation Rates.Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8.Preparation of tri(ethylene glycol) grafted core-shell type polymer support for solid-phase peptide synthesis.Bcl-XL-binding helical peptides possessing d-Ala residues at their C-termini with the advantage of long-lasting intracellular stabilities.Modulators of 14-3-3 Protein-Protein Interactions.Peptide Macrocycles Developed from Precisely Regulated Multiple Cyclization of Unprotected Peptides.General and Facile Route to Isomerically Pure Tricyclic Peptides Based on Templated Tandem CLIPS/CuAAC Cyclizations.Stabilization of peptides against proteolysis through disulfide-bridged conjugation with synthetic aromatics.Precisely Regulated and Efficient Locking of Linear Peptides into Stable Multicyclic Topologies through a One-Pot Reaction.Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity.Constructing thioether-tethered cyclic peptides via on-resin intra-molecular thiol-ene reaction.Protease-Activatable Scaffold Proteins as Versatile Molecular Hubs in Synthetic Signaling NetworksA Binary Bivalent Supramolecular Assembly Platform Based on Cucurbit[8]uril and Dimeric Adapter Protein 14-3-3Model foldamers: applications and structures of stable macrocyclic peptides identified using in vitro selection14-3-3 proteins activate Pseudomonas exotoxins-S and -T by chaperoning a hydrophobic surface
P2860
Q27324625-DAD53F82-5C0C-4D65-B0DA-FDA2A2E9ED4AQ27703615-B06E8E13-66B1-4B9B-A229-6D91B60D82CAQ27728007-F1C21655-84C2-4157-8975-92B322456831Q28553736-D0665650-C9BB-4A1B-9537-4DE8D4286173Q33814121-35D80F48-51EB-42F2-A5FF-6771D44B9BE9Q35194362-CEDC340B-A677-49BE-A4B1-1CEF526CF3EAQ35447214-701DAC93-678D-46B7-BEF2-F321729C6D4AQ35558196-35C7D2D9-2AB0-49DE-8A32-58BDE1B73229Q35824701-0EFB19EF-438E-4F2A-BA4E-EDFC0C05BB6DQ37135807-66FFCA6D-A133-446D-8011-BE24C34ADAE5Q37712074-099F3612-958A-4D8E-86B0-B87D7CBE535FQ38289100-EA3C7E17-37E8-4904-8BA2-6BEBBBAC22FFQ38314370-057BA645-57B3-4659-B4D3-6087915E1DC2Q38539666-DBC3EDBC-23FA-4445-BB8E-566A5BA18DFDQ38801977-6B667097-0468-4B60-9DF6-5D65940849BEQ38889986-4352028D-07B1-42FB-8240-37A20F05ADA4Q39072845-F1F6BE17-916C-4917-92B4-920727E4E066Q39852763-D90A96C9-1112-4792-B30E-61DFFE528E91Q41246646-6EDB1C02-C9C4-4D68-B526-43E4EC4507E8Q41551637-8D71A844-A584-4531-A22B-9D6A672700E3Q43402247-19F758D5-0EFB-4386-A637-3110BD316FC2Q44233305-6ACF8F4E-A79B-4925-AC9F-850FF68CAE9CQ46575190-3EE4B041-54A2-46D8-8E71-05FA38ADC2E8Q47095079-83FB67C5-F4A9-4717-84E7-566D20204D54Q47161501-82232FA9-8A09-4CA2-8EB0-1797E612306AQ47255129-E17DA491-1903-4C36-943A-16375350A31EQ47601044-1E074BD5-BBE8-4EF1-909E-4DABDDCCE08CQ47610334-3E77CB34-FD35-43F2-BF8A-CFF9105B1944Q47763404-72DA03B9-6744-4867-B622-7E66DE83BB80Q48199877-F4548A7F-7E51-4D17-BF26-80A94D74BA50Q48263291-62047CCB-732E-491A-86F1-E318596D71CCQ48820981-FCA4E661-1663-4916-8FAB-931004F0E7C0Q53185344-7AA56292-A8A2-44F4-B8FE-D59CCD128FA4Q53862367-08A8CDBF-6137-4A0C-A813-B3E707E02E2AQ57531335-E09D0B15-1307-4C14-93A9-D4C8C88F48D8Q57531343-BF4C9AE6-6DAB-4C0B-89C7-90CADA69B7E8Q57840920-AFE336C6-0E08-4463-B055-C2B5069048B7Q58319170-6862C90C-899A-4097-9CF1-4B3C67C2BB23
P2860
Constrained peptides with target-adapted cross-links as inhibitors of a pathogenic protein-protein interaction
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Constrained peptides with targ ...... ic protein-protein interaction
@ast
Constrained peptides with targ ...... ic protein-protein interaction
@en
Constrained peptides with targ ...... ic protein-protein interaction
@nl
type
label
Constrained peptides with targ ...... ic protein-protein interaction
@ast
Constrained peptides with targ ...... ic protein-protein interaction
@en
Constrained peptides with targ ...... ic protein-protein interaction
@nl
prefLabel
Constrained peptides with targ ...... ic protein-protein interaction
@ast
Constrained peptides with targ ...... ic protein-protein interaction
@en
Constrained peptides with targ ...... ic protein-protein interaction
@nl
P2093
P2860
P3181
P356
P1476
Constrained peptides with targ ...... ic protein-protein interaction
@en
P2093
Adrian Glas
David Bier
Gernot Hahne
Tom N Grossmann
P2860
P304
P3181
P356
10.1002/ANIE.201310082
P407
P577
2014-02-24T00:00:00Z